● Single award · contract
On Behalf of Niaid-Dcr, Facilitate the Conduct of Two, Randomized Trials as Detailed Below in I and II: I. A…
A single federal award, with both ends of the trail linked.
$89.6M
total award value
2020
action date
99 mo
period
75N91020F00009
PIID
Description
On Behalf of Niaid-Dcr, Facilitate the Conduct of Two, Randomized Trials as Detailed Below in I and II: I. A Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 (2,000 Subjects
Awarding agencyDepartment of Health and Human Services →
RecipientLeidos Biomedical Research Inc →
Place of performanceMaryland →
CategoryNAICS 541715PSC AN12
Competed?Not recorded✓ from source
Total (exact)$89,563,956
More awards to Leidos Biomedical Research Inc
awarded 2008$4.8B
awarded 2020$1.8B
awarded 2019$432.4M
awarded 2024$398.9M
awarded 2025$327.1M
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.